Markus Kosch, Head Oncology Europe and Canada at Daiichi Sankyo Europe GmbH, shared a post on LinkedIn:
“What does patient safety actually mean? After our Patient Safety Day at Daiichi Sankyo Europe GmbH, I am more convinced than ever: it is about seeing the whole person, not just the treatment.
We were privileged to hear directly from Diana Dragu and Katharina Bauer about the realities shaping their lives during treatment – from fertility and lactation, to the safety of their families at home, to the need for honest conversations about future plans. These are not ‘side topics’ – they are central to patient safety.
Pharmacovigilance helps us capture these lived experiences and turn them into knowledge we can act on. Listening alone is not enough. It is our responsibility to ensure these insights lead to tangible changes – in how we design our studies, how we counsel patients, and how we make sure our approach to treatment considers real-world needs.
I cannot emphasize enough that patient safety is truly a shared mission. From Medical Affairs to Pharmacovigilance, from clinical teams to affiliates, each of us plays an important role in making sure treatments are not only effective but also safe and supportive.
To patients and families – what aspects of safety matter most to you during and after treatment?”
More from Markus Kosch on OncoDaily.